Clinical trial Recruiting at 1 site Observational Ages 18 and up

Effect of pulmonary vein isolation on sleep breathing in people with paroxysmal atrial fibrillation

Official title: Assessment of Sleep Parameters Using Polygraphy in Patients With Paroxysmal Atrial Fibrillation Qualified for Pulmonary Vein Isolation - A Prospective Observational Study (AAHI Study)

Run by Primula Clinics · NCT07259200 · Data updated 2026-11-12

This study will test whether pulmonary vein isolation (a common AF ablation) changes sleep breathing measurements in people with paroxysmal atrial fibrillation who have risk factors for sleep apnea.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorPrimula Clinics
Academic / other
Locations1 site (Grodzisk Mazowiecki)
StatusRecruiting
StartedMarch 20, 2025
Main results expectedFebruary 1, 2026
Study endsFebruary 28, 2026
Registry record updatedDecember 2, 2025
Trial IDNCT07259200 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with paroxysmal atrial fibrillation scheduled for pulmonary vein isolation who have at least one risk factor for obstructive sleep apnea (for example, hypertension, male sex, BMI > 25, diabetes, excessive daytime sleepiness, or snoring).

Probably not a fit

People without OSA risk factors, those with persistent rather than paroxysmal AF, or those unable to attend in-person polygraphic testing are unlikely to benefit from this observational protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study enrolling adults with paroxysmal atrial fibrillation who are scheduled for pulmonary vein isolation. Participants will undergo four polygraphic sleep recordings at defined timepoints before and after the ablation to measure hypopnea index and other sleep parameters. Clinical data on AF episodes and obstructive sleep apnea risk factors will be collected alongside routine care without introducing experimental treatments. Sleep breathing metrics will be compared over time to see if rhythm-control therapy is associated with measurable changes in sleep-disordered breathing.

Why it matters

Potential benefit: If results show improved sleep parameters after ablation, clinicians may better predict which patients could see sleep benefits from rhythm-control therapy.

How similar studies have gone: Prior observational work has reported that restoring sinus rhythm can improve sleep-disordered breathing in some patients, but findings are variable and high-quality randomized data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (all must be met):

* Diagnosis of atrial fibrillation (AFib) and scheduled catheter ablation.
* Presence of at least one OSA risk factor: hypertension, male sex, BMI \> 25, diabetes, excessive daytime sleepiness, snoring.

Exclusion Criteria:

\- Absence of predefined sleep apnea risk factors.

Where it's running

  • Primula Clinics
    Grodzisk Mazowiecki, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.